The percentages of CD4+ T cells in PBMCs of health individuals (19.90 ± 9.02%), fibroadenoma (FIBma) (22.98 ± 7.51%) and IBCa patients (20.74 ± 8.84%) were comparable (P > 0.05; Fig. 1A,E). This evidence concerns the gene CD4 and Fibroadenoma.